mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |